UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

New photobiomodulation device for prevention and cure of radiotherapy-induced oral mucositis and dermatitis: results of the prospective Safe PBM study

Supportive care in cancer, 2022-02, Vol.30 (2), p.1569-1577

2022

Link zum Volltext

Verfügbarkeit prüfen

Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort

BMC cancer, 2022-12, Vol.22 (1), p.1318-1318, Article 1318

2022

Link zum Volltext

Verfügbarkeit prüfen

Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers

Cancers, 2020-12, Vol.13 (1), p.57

2020

Link zum Volltext

Verfügbarkeit prüfen

A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis

Drugs (New York, N.Y.), 2015-09, Vol.75 (13), p.1471-1482

2015

Link zum Volltext

Verfügbarkeit prüfen

Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer

Scientific reports, 2017-08, Vol.7 (1), p.10117-10117, Article 10117

2017

Link zum Volltext

Verfügbarkeit prüfen

Avelumab–cetuximab–radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH)

European journal of cancer (1990), 2020-12, Vol.141, p.21-29

2020

Link zum Volltext

Verfügbarkeit prüfen

Stereotactic reirradiation in the treatment of head and neck cancers: A retrospective study on the long-term experience of the Oscar Lambret Center

Radiotherapy and oncology, 2024-01, Vol.190, p.110029-110029, Article 110029

2024

Link zum Volltext

Verfügbarkeit prüfen

224 MuciLight trial: phase 2 of LED photobiomodulation for treatment of mucositis in oral cavity or oropharyngeal cancer

Radiotherapy and oncology, 2024-03, Vol.192, p.S274-S275

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx

European journal of cancer (1990), 2021-03, Vol.146, p.135-144

2021

Link zum Volltext

Verfügbarkeit prüfen

249 External validation of a predictive model for severe malnutrition developed on a multicenter real-life cohort from UNITRAD

Radiotherapy and oncology, 2024-03, Vol.192, p.S308-S309

2024

Link zum Volltext

Verfügbarkeit prüfen

NANORAY-312: A phase III pivotal study of NBTXR3 activated by investigator’s choice of radiotherapy alone or radiotherapy in combination with cetuximab for platinum-based chemotherapy-ineligible elderly patients with locally advanced head and neck squamous cell carcinoma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS6110-TPS6110

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficiency and Accuracy Evaluation of Multiple Diffusion‐Weighted MRI Techniques Across Different Scanners

Journal of magnetic resonance imaging, 2024-01, Vol.59 (1), p.311-322

2024

Link zum Volltext

Verfügbarkeit prüfen

Magnetic resonance imaging guided brachytherapy: Time for non-pelvic cancer? Example of tongue brachytherapy

Radiotherapy and oncology, 2021-02, Vol.155, p.e1-e2

2021

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial

Radiotherapy and oncology, 2024-04, Vol.193, p.110116-110116, Article 110116

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of hafnium oxide nanoparticles activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.6573-6573

2020

Link zum Volltext

Verfügbarkeit prüfen

International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers

Head & neck, 2024-06, Vol.46 (6), p.1253-1262

2024

Link zum Volltext

Verfügbarkeit prüfen

Radiation enhancing hafnium oxide nanoparticles (NBTXR3) for the treatment of cisplatin-ineligible locally advanced HNSCC patients: a phase I dose expansion study

Oral oncology, 2021-07, Vol.118, p.11-11

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of functionalized hafnium oxide nanoparticles (NBTXR3) activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.6051-6051

2021

Link zum Volltext

Verfügbarkeit prüfen

Hafnium oxide nanoparticles NBTXR3 activated by radiotherapy as a new therapeutic option for elderly/frail HNSCC patients

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.6069-6069

2019

Link zum Volltext

Verfügbarkeit prüfen

Influence of postoperative radiotherapy target volumes in unilateral head and neck carcinoma of unknown primary: A multicentric study using propensity score

Radiotherapy and oncology, 2021-07, Vol.160, p.1-8

2021

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensus

Radiotherapy and oncology, 2021-07, Vol.160, p.140-147

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 “PembroRad” trial

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.6018-6018

2018

Link zum Volltext

Verfügbarkeit prüfen

Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers

Cancers, 2021-01, Vol.13 (1)

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Englisch
(60)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(33)
Humans
(24)
Life Sciences
(24)
Oncology
(13)
Female
(10)
Infectious Diseases
(10)
Male
(10)
Cancer
(9)
Adult
(7)
Radiation Therapy
(7)
Radiology, Nuclear Medicine & Medical Imaging
(7)
Covid-19
(6)
Head & Neck Cancer
(6)
Radiotherapy
(6)
Aged
(5)
Computer Science
(5)
Head And Neck
(5)
Head And Neck Neoplasms - Radiotherapy
(5)
Human Health And Pathology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

New photobiomodulation device for prevention and cure of radiotherapy-induced oral mucositis and dermatitis: results of the prospective Safe PBM study

Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort

Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers

Harmonization of the Volume of Interest Delineation among All Eleven Radiotherapy Centers in the North of France

A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis

Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer

Avelumab–cetuximab–radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH)

Stereotactic reirradiation in the treatment of head and neck cancers: A retrospective study on the long-term experience of the Oscar Lambret Center

224 MuciLight trial: phase 2 of LED photobiomodulation for treatment of mucositis in oral cavity or oropharyngeal cancer

Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx

249 External validation of a predictive model for severe malnutrition developed on a multicenter real-life cohort from UNITRAD

NANORAY-312: A phase III pivotal study of NBTXR3 activated by investigator’s choice of radiotherapy alone or radiotherapy in combination with cetuximab for platinum-based chemotherapy-ineligible elderly patients with locally advanced head and neck squamous cell carcinoma

Efficiency and Accuracy Evaluation of Multiple Diffusion‐Weighted MRI Techniques Across Different Scanners

Magnetic resonance imaging guided brachytherapy: Time for non-pelvic cancer? Example of tongue brachytherapy

Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial

Phase I trial of hafnium oxide nanoparticles activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients

International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers

Radiation enhancing hafnium oxide nanoparticles (NBTXR3) for the treatment of cisplatin-ineligible locally advanced HNSCC patients: a phase I dose expansion study

Phase I study of functionalized hafnium oxide nanoparticles (NBTXR3) activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients

Hafnium oxide nanoparticles NBTXR3 activated by radiotherapy as a new therapeutic option for elderly/frail HNSCC patients

Influence of postoperative radiotherapy target volumes in unilateral head and neck carcinoma of unknown primary: A multicentric study using propensity score

Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer: A Phase 3 Randomized Clinical Trial

Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensus

A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 “PembroRad” trial

Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers

Suchergebnisse filtern